David A. Siegel Ginkgo Bioworks Holdings, Inc. Transaction History
Two Sigma Advisers, LP
- $43.8 Billion
- Q2 2024
A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Ginkgo Bioworks Holdings, Inc. stock. As of the latest transaction made, Two Sigma Advisers, LP holds 31,443,550 shares of DNA stock, worth $198 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
31,443,550
Previous 1,131,043
2680.05%
Holding current value
$198 Million
Previous $1.31 Million
690.85%
% of portfolio
0.02%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding DNA
# of Institutions
347Shares Held
925MCall Options Held
1.04MPut Options Held
2.23M-
Viking Global Investors LP143MShares$903 Million0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA139MShares$877 Million0.0% of portfolio
-
Baillie Gifford & CO134MShares$848 Million0.04% of portfolio
-
Anchorage Capital Group, L.L.C. New York, NY69.9MShares$441 Million7.28% of portfolio
-
Black Rock Inc. New York, NY42MShares$265 Million0.0% of portfolio
About Ginkgo Bioworks Holdings, Inc.
- Ticker DNA
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 1,287,779,968
- Market Cap $8.13B
- Description
- Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...